{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:27:26Z","timestamp":1788564446765,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.nano.2020.102259","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T02:53:36Z","timestamp":1593572016000},"page":"102259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["In vitro and in vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC)"],"prefix":"10.1016","volume":"29","author":[{"given":"C.","family":"Vairo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Basas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Palau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Gomis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gainza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Igartua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gavald\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gainza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2020.102259_bb0005","author":"World Health Organization"},{"issue":"3","key":"10.1016\/j.nano.2020.102259_bb0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Magrini N; WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nano.2020.102259_bb0035","author":"Alliance for the Prudent Use of Antibiotics (APUA)"},{"issue":"6","key":"10.1016\/j.nano.2020.102259_bb0040","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00063198-200111000-00013","article-title":"The clinical use of colistin in patients with cystic fibrosis","volume":"7","author":"Beringer","year":"2001","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.nano.2020.102259_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/14787210.2014.878648","article-title":"Aminoglycoside toxicity in neonates: something to worry about?","volume":"12","author":"Kent","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.nano.2020.102259_bb0050","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nano.2019.02.014","article-title":"Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration","volume":"18","author":"Pastor","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2020.102259_bb0055","doi-asserted-by":"crossref","first-page":"118484","DOI":"10.1016\/j.ijpharm.2019.118484","article-title":"Preclinical safety of topically administered nanostructure lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies","volume":"569","author":"Vairo","year":"2019","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.nano.2020.102259_bb0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijpharm.2014.10.048","article-title":"Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis","volume":"477","author":"Pastor","year":"2014","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.nano.2020.102259_bb0065","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13346-011-0023-5","article-title":"Chitosan-coated solid lipid nanoparticles enhance the oral absorption of insulin","volume":"1","author":"Fonte","year":"2011","journal-title":"Drug Deliv and Transl Res"},{"issue":"5","key":"10.1016\/j.nano.2020.102259_bb0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jps.2600790514","article-title":"Comparison of new and existing spectrophotometric methods of analysis of tobramycin and other aminoglycosides","volume":"79","author":"Sampath","year":"1990","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.nano.2020.102259_bb0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2011.08.010","volume":"157","author":"Ungaro","year":"2012","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.nano.2020.102259_bb0085","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/JCM.42.5.1915-1922.2004","article-title":"Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis","volume":"42","author":"Moskowitz","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.nano.2020.102259_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/48.1.7","article-title":"Antimicrobial effects of positively charged surface on adhering gram-positive and gram-negative bacteria","volume":"48","author":"Gottenbos","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2020.102259_bb0095","series-title":"National Research Council. Guide for the care and use of laboratory animals: eighth edition","year":"2011"},{"issue":"4","key":"10.1016\/j.nano.2020.102259_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/jac\/45.4.493","article-title":"Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia","volume":"45","author":"Rodriguez-Hernandez","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.nano.2020.102259_bb0105","first-page":"285","article-title":"Effect of dextan molecular weight on protein stabilization during freeze-drying and storage","volume":"22","author":"Sun","year":"2001","journal-title":"Cryo Letters"},{"issue":"1","key":"10.1016\/j.nano.2020.102259_bb0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijfoodmicro.2010.09.012","article-title":"Antimicrobial properties of chitosan and mode of action: a state of the art review","volume":"144","author":"Kong","year":"2010","journal-title":"Int J Food Microbiol"},{"issue":"8","key":"10.1016\/j.nano.2020.102259_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160877","article-title":"Stability and biological activity evaluation of chlorantraniliprole solid nanodispersions prepared by high pressure homogenization","volume":"11","author":"Cui","year":"2016","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.nano.2020.102259_bb0120","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jac\/dkn059","article-title":"Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections","volume":"61","author":"Meers","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"13","key":"10.1016\/j.nano.2020.102259_bb0125","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.biomaterials.2008.12.076","article-title":"The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles","volume":"30","author":"Suk","year":"2009","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.nano.2020.102259_bb0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.nano.2020.102259_bb0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery \u2014 drug release and release mechanism","volume":"45","author":"zur M\u00fchlen","year":"1998","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"10.1016\/j.nano.2020.102259_bb0140","article-title":"Development of liposomal ciprofloxacin to treat lung infections","volume":"8","author":"Cipolla","year":"2016","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.nano.2020.102259_bb0145","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0006-3495(96)79407-9","article-title":"Is trehalose special for preserving dry biomaterials?","volume":"71","author":"Crowe","year":"1996","journal-title":"Biophys J"},{"key":"10.1016\/j.nano.2020.102259_bb0150","series-title":"Quaternary ammonium surface-active disinfectants. In disinfection, sterilization and preservation","first-page":"430","author":"Lawrence","year":"1968"},{"issue":"10","key":"10.1016\/j.nano.2020.102259_bb0155","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11051-016-3611-y","article-title":"Positively charged biopolymeric nanoparticles for the inhibition of Pseudomonas aeruginosa biofilms","volume":"18","author":"Chronopoulou","year":"2016","journal-title":"J Nanopart Res"},{"issue":"8","key":"10.1016\/j.nano.2020.102259_bb0160","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1021\/es103450g","article-title":"Diffusion of nanoparticles in a biofilm","volume":"45","author":"Peulen","year":"2011","journal-title":"Environ Sci Technol"},{"issue":"2","key":"10.1016\/j.nano.2020.102259_bb0165","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejpb.2012.03.015","article-title":"Curcumin loaded NLC induces histone hypoacetylation in the CNS after intraperitoneal administration in mice","volume":"81","author":"Puglia","year":"2012","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963420301131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963420301131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:11:05Z","timestamp":1761549065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963420301131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":28,"alternative-id":["S1549963420301131"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2020.102259","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo antimicrobial activity of sodium colistimethate and amikacin-loaded nanostructured lipid carriers (NLC)","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2020.102259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102259"}}